The overall goal of the Administrative Core of the University of Chicago (UChicago) Digestive Diseases Research Core Center (DDRCC) for Interdisciplinary Study of Inflammatory Intestinal Disorders (C-IID), is to provide leadership and strategic vision to foster and expand research in the field of inflammatory diseases of the bowel by its clinical and basic science faculty, particularly in the areas of microbiology, immunology, genetics/genomics and translational and clinical research. These themes have defined our GI program over 75 years ago when Dr. Joseph B Kirsner put forward the hypothesis that IBD was caused by genetic, immunological, and microbial factors. The C-IID Administrative Core leadership is provided by Dr. Bana Jabri, Director, Dr. Eugene Chang Co-Director, and Dr. John Alverdy, Associate Director with the help of their administrative staff and the C-IID Program Manager, in conjunction with the Executive Committee, the Internal Advisory Committee, and the External Advisory Committee. The Administrative Core will be responsible for overseeing all aspects of the C-IID, including strategic, scientific, and operational directions to insure effectiveness and impact of the program. It will continue to seek opportunities to foster interaction and collaborations among its members. It will also identify member needs, and optimize member benefits from Center Cores and Programs The administrative leadership also assures responsiveness of the C-IID Cores to the needs of the members and provides oversight for Core functions. This has led, for instance, to the addition of two computational scientists to help members with the analysis of host and microbial next-generation sequencing data, and the creation of the Multiparametric Host Cell Analysis core to promote utilization of state-of-the-art genomic technologies and enhance research in human immunology and tissue cell analysis in the field of DD. The proceedings of the monthly Executive Committee and Administrative Core meetings are reviewed on an annual basis by the Internal Advisory Board (comprised of selected, prominent, senior leaders in the Biological Sciences Division with expertise relevant to the goals of the C-IID) and the Dean of Biological Sciences, Dr. Kenneth Polonsky. The Executive Committee consists of C-IID leadership, prominent University of Chicago digestive diseases investigators. As the neutral review and sounding board, the External Advisory Board of the C- IID reviews all requests, reports, and recommendations of the Executive Committee. The members of the External Advisory Board include 5 internationally renowned investigators who are leaders in the area of digestive diseases, particularly in the focus areas of the C-IID. In summary, the Administrative Core of the C-IID provides leadership, programmatic vision, oversight, and management of a highly multidisciplinary and innovative program that foster interaction, collaboration, and synergy in studies of inflammatory diseases of the bowel.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Chicago
United States
Zip Code
Amin, Ruhul; Asplin, John; Jung, Daniel et al. (2018) Reduced active transcellular intestinal oxalate secretion contributes to the pathogenesis of obesity-associated hyperoxaluria. Kidney Int 93:1098-1107
Miyoshi, Jun; Nobutani, Kentaro; Musch, Mark W et al. (2018) Time-, Sex-, and Dose-Dependent Alterations of the Gut Microbiota by Consumption of Dietary Daikenchuto (TU-100). Evid Based Complement Alternat Med 2018:7415975
Lu, Jing; Lu, Lei; Yu, Yueyue et al. (2018) Effects of Intestinal Microbiota on Brain Development in Humanized Gnotobiotic Mice. Sci Rep 8:5443
Meisel, Marlies; Hinterleitner, Reinhard; Pacis, Alain et al. (2018) Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557:580-584
Chen, Edmund B; Cason, Cori; Gilbert, Jack A et al. (2018) Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions. J Gastrointest Surg 22:1112-1123
Chew, Justin; Leypunskiy, Eugene; Lin, Jenny et al. (2018) High protein copy number is required to suppress stochasticity in the cyanobacterial circadian clock. Nat Commun 9:3004
Ruderman, Sarah; Eshein, Adam; Valuckaite, Vesta et al. (2018) Early increase in blood supply (EIBS) is associated with tumor risk in the Azoxymethane model of colon cancer. BMC Cancer 18:814
Dugas, Lara R; Lie, Louise; Plange-Rhule, Jacob et al. (2018) Gut microbiota, short chain fatty acids, and obesity across the epidemiologic transition: the METS-Microbiome study protocol. BMC Public Health 18:978
McIntosh, Christine M; Chen, Luqiu; Shaiber, Alon et al. (2018) Gut microbes contribute to variation in solid organ transplant outcomes in mice. Microbiome 6:96
Overstreet, A M; LaTorre, D L; Abernathy-Close, L et al. (2018) The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis. Mucosal Immunol 11:1454-1465

Showing the most recent 10 out of 697 publications